arrow
T

Thomas Vanwolleghem

University of Antwerp
H指数:38
被引数:5,802

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ethnicity, genomic ancestry, and HBV genotype in off-treatment outcomes following nucleos(t)ide analogue cessation: a prospective multicentre trial (COIN-B)

种族、基因组祖先及HBV基因型在核苷(酸)类似物停药后疗效中的作用:一项前瞻性多中心试验(COIN-B)

2026-10-080
OAAI
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort (vol 8, 101898, 2026)

慢性丁型肝炎伴轻度至中度纤维化进展为肝硬化的进程:来自多中心欧洲队列的见解(卷8,101898,2026)

2026-09-010
OA
The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birth

病毒性肝炎预防委员会(VHPB)支持继续推荐对所有新生儿在出生后24小时内进行常规乙型肝炎疫苗接种。

2025-12-310
PRE
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD

使用非侵入性检测预测当代多中心队列中cACLD患者的肝功能失代偿

2025-11-040
PRE
Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue Cessation

临床试验:乙型肝炎病毒基因型和一组治疗结束生物标志物预测核苷(酸)类似物停药后的严重肝炎发作

2025-11-010
PRE
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in chronic hepatitis B patients with advanced fibrosis

尽管肝硬度改善,慢性乙型肝炎合并进展期肝纤维化患者仍持续存在肝细胞癌风险

2025-08-200
OAAI
Development of a ribavirin dosing regimen in transplant recipients with chronic hepatitis E virus infection: a population pharmacokinetic and -dynamic model

利巴韦林给药方案在慢性丙型肝炎病毒感染移植受者中的开发:一种群体药代动力学和药效动力学模型

2025-06-010
PRE
Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B
2025-03-010
PRE
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

肝静脉压力梯度预测MASLD患者肝功能失代偿和肝脏相关死亡率的风险

2024-11-014
OAAI
Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy
2024-07-012
OAAI
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International Network

全球不同地区肝炎三角洲的长期结果: 肝炎三角洲国际网络的结果

2024-06-184
OAAI
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)

有限的持续缓解后核苷 (酸) ide类似物退出: 从慢性乙型肝炎患者的大型,全球性,多种族队列的结果 (RETRACT-B研究)

2024-05-140
PRE
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
2024-04-0120
OAAI